Evidence Of The Neuroprotective Role Of Citicoline In Glaucoma Patients
Notes for this study:
|Number of Subjects
1600mg oral CDP-choline to persons with glaucoma and minor visual impairment for 60 days (with 180 days of followup) noted that CDP-choline was associated with improvements in visual functoning without any influence on intraocular pressure. Although a control was used in this study, there was no blinding protocol.